ZE74-0282

· Eilean Therapeutics AU Pty Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ZE74-0282, covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers [Phase 1]